XML 97 R39.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCKHOLDERS' EQUITY (Tables)
 12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule of Common Stock
The following table shows the beginning and ending balances of our issued and outstanding common stock for the years ended December 31, 2024, 2023, and 2022:
Year Ended
December 31,
202420232022
Shares issued and outstanding, beginning balance50,664,471 60,555,661 65,968,224 
Issuance of common stock from vested restricted stock units758,737 774,579 841,861 
Issuance of common stock from exercise of stock options
8,208 182,067 116,592 
Issuance of common stock for employee stock purchase plan
148,157 175,446 158,134 
Issuance of common stock for the acquisition of Zenefits— — 193,221 
Repurchase of common stock
(1,771,254)(10,734,790)(6,398,279)
Awards effectively repurchased for required employee withholding taxes
(280,813)(288,492)(324,092)
Shares issued and outstanding, ending balance
49,527,506 50,664,471 60,555,661 
Schedule of Stock Repurchase
The following table summarizes the share repurchases under this program for the years ended December 31, 2024, 2023 and 2022:
Year Ended
December 31,
202420232022
Total cost (in millions)$182 $1,112 $519 
Total shares1,771,254 10,734,790 6,398,279 
Average price per share$102.84 $103.59 $81.07